SEC Form 4 · accession 0001193125-26-340543
Disc Medicine, Inc. · IRON
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rahul Khara
Officer — Chief Legal Officer
Period of report
Aug 6, 2026
Accepted (ET)
Aug 7, 2026 · 5:32 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001816736
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Aug 6, 2026 | M | 5,000 | $14.69 | A | 57,324 | D | |
| Common StockF2 | Aug 6, 2026 | S | 5,000 | $80.00 | D | 52,324 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $14.69 | Aug 6, 2026 | M | 5,000 | D | — | Feb 7, 2032 | Common Stock | 5,000 | 49,804 | D |
Explanation of responses
- F1The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026.
- F2Includes 151 shares purchased pursuant to the Disc Medicine, Inc. Amended and Restated 2021 Employee Stock Purchase Plan on July 31, 2026.
- F3The shares underlying this option are fully vested and exercisable as of the date hereof.